Can a new vaccine shield older adults from RSV?
NCT ID NCT05639894
First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time
Summary
This trial evaluates an experimental vaccine designed to protect against respiratory syncytial virus (RSV), a common virus that can be severe in older adults. The study includes healthy adults aged 18 to 50 in an early phase, and adults 60 and older in a later phase. Participants receive either one of several vaccine doses or a placebo, and researchers monitor safety and measure the immune response, including neutralizing antibodies against RSV types A and B. The goal is to find a dose that is both safe and effective for further development.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- An experimental RSV vaccine candidate formulated with lipid nanoparticles, given as an injection
- What this could lead to
- If successful, this could lead to a new vaccine that protects older adults from severe RSV infections.
- What could go wrong
- This is an early-stage trial, so the vaccine may not produce a strong immune response or could cause side effects. Results may not generalize to the broader population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS IMMUNIZATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AES Peoria Site Number : 8400030
Peoria, Illinois, 61614, United States
-
Aventiv Research Columbus Site Number : 8400007
Columbus, Ohio, 43213, United States
-
Aventiv Research Mesa Site Number : 8400020
Mesa, Arizona, 85210, United States
-
Be Well Clinical Studies -Round Rock Site Number : 8400038
Round Rock, Texas, 78681, United States
-
Be Well Clinical Studies Site Number : 8400036
Lincoln, Nebraska, 68516, United States
-
CVS Health - Peoria Site Number : 8400042
Peoria, Arizona, 85381, United States
-
CVS Health - Phoenix Site Number : 8400041
Phoenix, Arizona, 85019, United States
-
CVS Health - Thousand Oaks Site Number : 8400043
Thousand Oaks, California, 91361, United States
-
Cenexel Research Centers of America Site Number : 8400024
Hollywood, Florida, 33024, United States
-
Centricity Research - Georgia Site Number : 8400009
Rincon, Georgia, 31326, United States
-
Coastal Carolina Research Center Site Number : 8400015
North Charleston, South Carolina, 29405, United States
-
DM Clinical Research - Chicago Site Number : 8400027
River Forest, Illinois, 60305, United States
-
DM Clinical Research - CyFair Site Number : 8400025
Houston, Texas, 77065, United States
-
IMA Clinical Research-San Antonio Site Number : 8400039
San Antonio, Texas, 78229, United States
-
Investigational Site Number : 0360001
Southport, 4215, Australia
-
Investigational Site Number : 0360002
Camberwell, Victoria, 3124, Australia
-
Investigational Site Number : 0360003
Botany, New South Wales, 2019, Australia
-
Investigational Site Number : 6300001
San Juan, 00909, Puerto Rico
-
Investigational Site Number : 6300002
San Juan, 00918, Puerto Rico
-
Investigational Site Number : 6300003
Guayama, 000784, Puerto Rico
-
Investigational Site Number : 6300004
Carolina, 984, Puerto Rico
-
Investigational Site Number : 6300005
Guaynabo, 00968, Puerto Rico
-
Lynn Institute of Norman Site Number : 8400023
Norman, Oklahoma, 73072, United States
-
Martin Diagnostic Clinic Site Number : 8400026
Tomball, Texas, 77375, United States
-
Optimal Research Alabama Site Number : 8400032
Huntsville, Alabama, 35802, United States
-
Peninsula Research Associates Site Number : 8400013
Rolling Hills Estates, California, 90274, United States
-
Suncoast Research Associates, LLC Site Number : 8400003
Miami, Florida, 33173, United States
-
Velocity Clinical Research - Providence Site Number : 8400006
East Greenwich, Rhode Island, 02818, United States
-
Velocity Clinical Research - San Diego - ERN - PPDS Site Number : 8400010
La Mesa, California, 91942, United States
-
Velocity Clinical Research Site Number : 8400017
Cleveland, Ohio, 44122, United States
-
Velocity Clinical Research Site Number : 8400018
West Jordan, Utah, 84088-8865, United States
-
Velocity Clinical Research Site Number : 8400019
Cincinnati, Ohio, 45242, United States
-
Velocity Clinical Research, Medford Site Number : 8400014
Medford, Oregon, 97504, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One shot, two viruses: could a combined vaccine shield seniors from RSV and HMPV?
- RSV shot uptake under the microscope: how many german babies get protected?
- Double defense: new mRNA vaccine targets two lung viruses in seniors
- New RSV shots slash baby hospitalizations? study digs into Real-World data
- New mRNA vaccine candidates for RSV enter human testing